Global Market For Molecular Imaging Devices To Reach Nearly $3 Billion By 2018

Unlike traditional diagnostic tools, molecular imaging devices use biomarkers to identify diseases. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. An aging global population, advances in nanotechnology and robotics, as well as increasing demand for more accurate and efficient imaging systems will drive steady growth in this market over the next five years.

BCC Research provides an in-depth analysis of the global market for molecular imaging devices through its report Global Markets and Technologies for Molecular Imaging Devices. According to the report, this market was valued at $2 billion in 2012 and is expected to reach $2.2 billion in 2013. BCC Research projects the market to grow to nearly $3 billion by 2018, and register a five-year compound annual growth rate of 6.2% from 2013 to 2018.

Use this report to:

• Gain an overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.
• Analyze global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.
• Examine factors driving growth, market figures related to the current value of molecular imaging equipment, market shares, and key players.
• Assess the competitive landscape, leading pipeline products, pricing, and technology offerings.
• Identify the types of molecular imaging devices, including stand-alone planar imaging, PET, PET-CT, SPECT, and SPECT-CT.
• Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter, click here.

RSS Feeds – Healthcare